SCHEMBL3583187

SCHEMBL3583187

Oc1nnc(O)c(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MAPK1 P28482 1/20 0.46
BCL2L1 Q07817 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
MMP3 P08254 1/20 0.43
ALDH1A1 P00352 2/20 0.42
BACE1 P56817 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20792796 0.74 PDE4A (0.48) RAB9ABCL2L1LMNAMAPTHTT
SCHEMBL3164324 0.74 BCL2L1 (0.40) NPC1RAB9AMAPK1BCL2L1LMNA
SCHEMBL29001722 0.73 PDE4B (0.58) BCL2L1LMNAMAPTHTTMMP3
SCHEMBL1754108 0.73 PDE4B (0.52) BCL2L1LMNAMAPTHTTMMP3
SCHEMBL5182269 0.72 MEN1 (0.50) NPC1RAB9AMAPK1LMNAMAPT
SCHEMBL216526 0.71 ALDH1A1 (0.67) NPC1RAB9AMAPK1BCL2L1LMNA
SCHEMBL1760592 0.71 ESR2 (0.53) NPC1RAB9ABCL2L1LMNAMAPT
SCHEMBL4598394 0.71 PDE4B (0.56) BCL2L1LMNAMAPTHTTMMP3
SCHEMBL8644874 0.71 PDE4A (0.50) BCL2L1LMNAMAPTHTTMMP3
SCHEMBL14353864 0.71 PDE4B (0.50) BCL2L1LMNAMAPTHTTMMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-01-28 US disclosed
EP-2121628-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES Syngenta Participations AG (CH) 2009-11-25 EP disclosed
WO-2008089934-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES CYP4Z1, CYP1A2, CYP1A1 NPC1 3839/4885RAB9A 2942/4885MAPK1 906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.